Main reception, Gentilly, France
Main reception, Gentilly, France
Partnering with Sanofi
With our partners, we are creating a powerful ecosystem to accelerate innovation and advance medicines for all.
We Are Always on the Lookout for Game-Changing Science and Innovation Partners
Our ambition is clear: pioneer a new era in AI-powered R&D through our immunoscience-first approach.
This vision depends on strategic pharmaceutical partnerships and biotech collaborations throughout the entire drug development and commercialization journey. We prioritize collaborations with partners who share our vision for transformation.
Ready to explore partnership opportunities? Learn more about our active areas of interest and how we can collaborate to accelerate breakthrough innovations that improve patients' lives worldwide.
R&D External Innovation
We empower partners to turn innovative discoveries into transformative solutions through unique Awards and partnering models together with end-to-end support.
Business Development
We're all about flexibility. With broad range and global scope, our team fully supports any partnership's strategic intent. Whether licensing, R&D, joint ventures, or alliances, we collaborate with partners to bring innovative science to patients.
Sanofi Ventures
Investing in early-stage biotech and digital health companies of strategic interest, we offer our portfolio companies select access to expertise and capabilities, supporting our shared goal to improve the lives of patients.
Alliance Management
We ensure seamless execution across all supported partnerships, from academic and public-private collaborations to startup and in-licensing agreements. We provide consistent guidance that keeps you connected and drives shared success. Together, we can go further, faster, improving lives worldwide.
A Human-Centric Approach to Partnership
At a time when science is moving faster than ever, we believe true breakthroughs are born from collaboration. Pharmaceutical partnerships aren’t just a market trend for us; they’re a core philosophy. Discover our strategic approach to building lasting, transparent relationships that nurture promising science and deliver life-changing value to patients.
"Partnering with Sanofi has been highly productive. Their innovative Award Programs and flexible collaboration models have enabled us to advance impactful, data-driven research integrating AI with deep mechanistic insight. I've been impressed by their collaborative mindset and support."
Fei Wang, Ph.D., Founding Director for the Institute of AI for Digital Health, Weill Cornell Medicine
“Earendil Labs was founded on the belief that AI can transform biologic therapy discovery. By combining our AI-powered platform with Sanofi’s global capabilities in immunology, we aim to accelerate next-generation autoimmune therapies and deliver meaningful outcomes for patients"
Dr. Jian Peng, Founder & CEO, Earendil Labs
“Our work combines wearable technology, AI-driven analytics & digital biomarkers to enable continuous patient monitoring and generate deeper health insights. Since Sanofi Ventures investment, we've scaled across multiple therapeutic programs, integrating AI-powered physiological monitoring into clinical trials and developing new digital biomarkers."
Matteo Lai, Co-Founder and CEO, Empatica